> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# RapidAI Gains Clearance for Large Vessel Occlusions
- URL: https://www.fdaweb.com/rapidai-gains-clearance-for-large-vessel-occlusions/
- Published: 2020-08-13T12:00:00.000Z
- Updated: 2026-09-14T16:24:55.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5147427

FDA has cleared a RapidAI 510(k) for the Rapid LVO for detecting suspected large vessel occlusions (LVOs). The device, which provides results in about three minutes, uses a vessel tracker in conjunction with an assessment of brain regions with reduced blood vessel density to identify suspected LVOs with a sensitivity of 97% and a specificity of 96%, the company says. Stroke team members are also immediately notified when a suspected LVO is detected, it says.